 Pharma stocks continued their recovery in the September series after consolidation was seen in the last couple of months. The first round of recovery was seen in May and June when the broader market was under pressure. The Pharma Index gained almost 18% from May lows. We believe a fresh uptrend may be seen in the pharma space where stocks like Cipla are likely to pick up momentum. |
Action: Buy, Target Price:  780, Time Frame: 3 Months
MORE WILL UPDATE SOON!!
|
Saturday, 15 September 2018
Subscribe to:
Post Comments (Atom)
Comprehensive ways for investing are recommended here.
ReplyDeleteFree Stock Tips
Great t blog for learning share market and trading. I like to read this blog everyday. Free Stock Tips.
ReplyDelete